Covid 19 Convalescent Plasma Study
Convalescent plasma therapy involves the transfusion of plasma collected from a donor who has recovered from Covid-19 to a patient with an active infection. Two recent studies have shown that convalescent plasma therapy can be used in treating critically-ill covid-19 patients. Penn’s recently launched two part study will investigate how convalescent plasma therapy works in moderately and severely ill patients. We are talking to Principal Investigator of the study Dr. Katharine Bar to understand the nuances of the study.